RxDoctor Payments Data

Robin Ockey, MD

Pain Medicine · Provo, UTNPI 1326046160

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 69.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $436 and has fallen 81.5% since, to $81 in 2023. That places this record below the midpoint for pain medicine clinicians in UT, where the typical reported total is $3,451.

$650in general payments, 2019–2025

Across 13 payments — averaging $50.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$451
  • Boston Scientific$42
  • Stratus Medical, LLC$30
  • Stryker$24
  • Hikma Pharmaceuticals USA$21
  • Indivior Inc.$21
  • plus $61 from 4 others

What the payments were for

  • Food & beverage$62997%
  • Education$213%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott3$451
Boston Scientific2$42
Stratus Medical, LLC1$30
Stryker1$24
Hikma Pharmaceuticals USA1$21
Indivior Inc.1$21
Teva Pharmaceuticals USA, Inc.1$17
AbbVie1$16
Pfizer1$16
Medtronic1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$650 in reported general payments places this provider in the 25th percentile of 61 pain medicine providers in Utah.

See all pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$15,531
Medicare patients
25
Services billed
1,256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →